Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Wierda

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|March 29, 2023
Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic LeukemiaTi'ara L Griffen, Fieke W Hoff, Yihua Qiu, et al.
Cancer|December 6, 2011
The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemiaRavin Garg, William Wierda, Alessandra Ferrajoli, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
Leukemia & Lymphoma|June 13, 2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinibMichael Frei, Samuel L Aitken, Nitin Jain, et al.
Leukemia & Lymphoma|October 1, 2019
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)Mansour Alfayez, Beenu Thakral, Preetesh Jain, et al.
Leukemia Research|October 19, 2006
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 yearsAhmed Aribi, Yang Huh, Michael Keating, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2012
Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II studyAsifa Malik, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Blood|November 28, 2007
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapySusan O'Brien, Farhad Ravandi, Todd Riehl, et al.
Annals of the American Thoracic Society|August 31, 2013
Pneumonia during remission induction chemotherapy in patients with acute leukemiaJavier Barreda Garcia, Xiudong Lei, William Wierda, et al.
Cancer|March 13, 2009
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Farhad Ravandi, et al.
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|March 29, 2023
Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic LeukemiaTi'ara L Griffen, Fieke W Hoff, Yihua Qiu, et al.
Cancer|December 6, 2011
The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemiaRavin Garg, William Wierda, Alessandra Ferrajoli, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
Leukemia & Lymphoma|June 13, 2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinibMichael Frei, Samuel L Aitken, Nitin Jain, et al.
Leukemia & Lymphoma|October 1, 2019
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)Mansour Alfayez, Beenu Thakral, Preetesh Jain, et al.
Leukemia Research|October 19, 2006
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 yearsAhmed Aribi, Yang Huh, Michael Keating, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2012
Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II studyAsifa Malik, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Blood|November 28, 2007
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapySusan O'Brien, Farhad Ravandi, Todd Riehl, et al.
Annals of the American Thoracic Society|August 31, 2013
Pneumonia during remission induction chemotherapy in patients with acute leukemiaJavier Barreda Garcia, Xiudong Lei, William Wierda, et al.
Cancer|March 13, 2009
Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Farhad Ravandi, et al.
Pageof 19